BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 7657022)

  • 1. Insulin-stimulated muscle glucose clearance in patients with NIDDM. Effects of one-legged physical training.
    Dela F; Larsen JJ; Mikines KJ; Ploug T; Petersen LN; Galbo H
    Diabetes; 1995 Sep; 44(9):1010-20. PubMed ID: 7657022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic pathways of glucose in skeletal muscle of lean NIDDM patients.
    Kelley DE; Mokan M; Mandarino LJ
    Diabetes Care; 1993 Aug; 16(8):1158-66. PubMed ID: 8375246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of gene expression and activity of hexokinase, phosphofructokinase and glycogen synthase in human skeletal muscle in states of altered insulin-stimulated glucose metabolism.
    Vestergaard H
    Dan Med Bull; 1999 Feb; 46(1):13-34. PubMed ID: 10081651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Training-induced enhancement of insulin action in human skeletal muscle: the influence of aging.
    Dela F; Mikines KJ; Larsen JJ; Galbo H
    J Gerontol A Biol Sci Med Sci; 1996 Jul; 51(4):B247-52. PubMed ID: 8680988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-induced hexokinase II expression is reduced in obesity and NIDDM.
    Pendergrass M; Koval J; Vogt C; Yki-Jarvinen H; Iozzo P; Pipek R; Ardehali H; Printz R; Granner D; DeFronzo RA; Mandarino LJ
    Diabetes; 1998 Mar; 47(3):387-94. PubMed ID: 9519744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple defects of both hepatic and peripheral intracellular glucose processing contribute to the hyperglycaemia of NIDDM.
    Vaag A; Alford F; Henriksen FL; Christopher M; Beck-Nielsen H
    Diabetologia; 1995 Mar; 38(3):326-36. PubMed ID: 7758880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unchanged gene expression of glycogen synthase in muscle from patients with NIDDM following sulphonylurea-induced improvement of glycaemic control.
    Vestergaard H; Lund S; Bjørbaek C; Pedersen O
    Diabetologia; 1995 Oct; 38(10):1230-8. PubMed ID: 8690177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of carbohydrate and fat fuels in human skeletal muscle: impact of obesity and NIDDM.
    Mandarino LJ; Consoli A; Jain A; Kelley DE
    Am J Physiol; 1996 Mar; 270(3 Pt 1):E463-70. PubMed ID: 8638694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical training increases muscle GLUT4 protein and mRNA in patients with NIDDM.
    Dela F; Ploug T; Handberg A; Petersen LN; Larsen JJ; Mikines KJ; Galbo H
    Diabetes; 1994 Jul; 43(7):862-5. PubMed ID: 8013748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular glucose and fat metabolism in identical twins discordant for non-insulin-dependent diabetes mellitus (NIDDM): acquired versus genetic metabolic defects?
    Vaag A; Alford F; Beck-Nielsen H
    Diabet Med; 1996 Sep; 13(9):806-15. PubMed ID: 8891456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose clearance in aged trained skeletal muscle during maximal insulin with superimposed exercise.
    Dela F; Mikines KJ; Larsen JJ; Galbo H
    J Appl Physiol (1985); 1999 Dec; 87(6):2059-67. PubMed ID: 10601150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skeletal muscle proteolysis is reduced in noninsulin-dependent diabetes mellitus and is unaltered by euglycemic hyperinsulinemia or intensive insulin therapy.
    Denne SC; Brechtel G; Johnson A; Liechty EA; Baron AD
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2371-7. PubMed ID: 7629232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of one-legged high-intensity interval training on insulin-mediated skeletal muscle glucose homeostasis in patients with type 2 diabetes.
    Dela F; Ingersen A; Andersen NB; Nielsen MB; Petersen HHH; Hansen CN; Larsen S; Wojtaszewski J; Helge JW
    Acta Physiol (Oxf); 2019 Jun; 226(2):e13245. PubMed ID: 30585698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strength training increases insulin-mediated glucose uptake, GLUT4 content, and insulin signaling in skeletal muscle in patients with type 2 diabetes.
    Holten MK; Zacho M; Gaster M; Juel C; Wojtaszewski JF; Dela F
    Diabetes; 2004 Feb; 53(2):294-305. PubMed ID: 14747278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects.
    Halberstam M; Cohen N; Shlimovich P; Rossetti L; Shamoon H
    Diabetes; 1996 May; 45(5):659-66. PubMed ID: 8621019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular defects in glucose metabolism in obese patients with NIDDM.
    Kelley DE; Mokan M; Mandarino LJ
    Diabetes; 1992 Jun; 41(6):698-706. PubMed ID: 1587397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased insulin receptor signaling and glycogen synthase activity contribute to the synergistic effect of exercise on insulin action.
    Christ-Roberts CY; Pratipanawatr T; Pratipanawatr W; Berria R; Belfort R; Mandarino LJ
    J Appl Physiol (1985); 2003 Dec; 95(6):2519-29. PubMed ID: 12909611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM.
    Bonadonna RC; Del Prato S; Bonora E; Saccomani MP; Gulli G; Natali A; Frascerra S; Pecori N; Ferrannini E; Bier D; Cobelli C; DeFronzo RA
    Diabetes; 1996 Jul; 45(7):915-25. PubMed ID: 8666143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin action and glucose metabolism in nondiabetic control and NIDDM subjects. Comparison using human skeletal muscle cell cultures.
    Henry RR; Abrams L; Nikoulina S; Ciaraldi TP
    Diabetes; 1995 Aug; 44(8):936-46. PubMed ID: 7622000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different sensitivity of glucose and amino acid metabolism to insulin in NIDDM.
    Luzi L; Petrides AS; De Fronzo RA
    Diabetes; 1993 Dec; 42(12):1868-77. PubMed ID: 8243833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.